KRYS · Krystal Biotech, Inc.

$332.27 +3.93 (+1.20%) At close · Aug 14

Market Cap

$9.83B

29.60M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Krish S. Krishnan	Chair and Chief Executive Officer	$846,167	$682,400	$4,104,825	$4,675,093	—	$134,000	$10,442,485
Suma Krishnan	President, R&D	$677,500	$414,923	$2,868,000	$2,973,978	—	$14,000	$6,948,401
Kathryn Romano	Chief Accounting Officer	$437,500	$223,256	$394,350	$1,189,591	—	$14,000	$2,258,697

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Krish S. Krishnan	Chair and Chief Executive Officer	$801,667	$714,560	$13,953,625	—	—	$133,800	$15,603,652
Suma Krishnan	President, R&D	$639,167	$414,700	$7,176,150	—	—	$13,800	$8,243,817
Kathryn Romano	Chief Accounting Officer	$416,667	$231,000	$2,392,050	—	—	$13,800	$3,053,517

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Krish S. Krishnan	Chair and Chief Executive Officer	$733,333	$487,500	$2,047,750	$2,852,511	—	$102,800	$6,223,894
Suma Krishnan	President, R&D	$575,000	$307,125	$1,228,650	$1,711,506	—	$13,200	$3,835,481
Kathryn Romano	Chief Accounting Officer	$391,667	$210,000	$819,100	$1,141,004	—	$13,200	$2,574,971
Andrew C. Orth	Chief Commercial Officer	$276,515	—	$819,100	$1,141,004	—	$27,709	$2,264,328

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Krish S. Krishnan	Chair and Chief Executive Officer	$644,845	$325,000	—	$2,189,636	—	$96,986	$3,256,467
Suma Krishnan	President, R&D	$514,833	$262,500	—	$2,189,636	—	$12,590	$2,979,559
Andrew C. Orth	Chief Commercial Officer	$445,833	$202,500	—	$2,189,636	—	$12,200	$2,850,169
Kathryn Romano	Chief Accounting Officer	$341,667	$175,000	—	$2,189,636	—	$12,200	$2,718,503

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Andrew C. Orth	Chief Commercial Officer	$283,333	$130,508	—	$8,579,300	—	$9,917	$9,003,058
Krish S. Krishnan	Chair and Chief Executive Officer	$580,997	$309,535	$3,218,708	$3,123,339	—	$118,400	$7,350,978
Suma Krishnan	President, R&D	$453,359	$243,600	$2,240,473	$2,174,089	—	$11,600	$5,123,121
Kathryn Romano	Chief Accounting Officer	$283,333	$157,500	$1,546,242	$1,500,427	—	$11,600	$3,499,102

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Kathryn Romano	Chief Accounting Officer	$190,580	$75,628	—	$1,720,684	—	$6,667	$1,993,559
Krish S. Krishnan	Chair and Chief Executive Officer	$498,220	$254,153	—	—	—	$11,400	$763,773
Suma Krishnan	President, R&D	$392,215	$200,078	—	—	—	$10,683	$602,976
Andrew C. Orth	Chief Commercial Officer	—	—	—	—	—	—	—

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Antony A. Riley	Chief Financial Officer	$141,667	—	—	$519,177	—	—	$660,844
Krish S. Krishnan	Chairman and Chief Executive Officer	$365,725	—	—	—	—	—	$365,725
Suma Krishnan	Chief Operating Officer	$305,642	—	—	—	—	—	$305,642
Pooja Agarwal	Senior Vice President, Product Development	$209,583	$50,000	—	—	—	—	$259,583
Kathryn Romano	Chief Accounting Officer	—	—	—	—	—	—	—

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Krish S. Krishnan	Chairman and Chief Executive Officer	$200,000	$235,000	$269,994	—	—	—	$704,994
Suma Krishnan	Chief Operating Officer	$200,000	$128,450	$166,994	—	—	—	$495,444
Pooja Agarwal	Senior Vice President, Product Development	$189,938	$40,000	—	$211,020	—	—	$440,958
Antony A. Riley	Chief Financial Officer	$103,561	—	—	$174,600	—	—	$278,161

Executive changes

Person	Role	Change	Effective	Filed
Kirti Ganorkar	Board of Directors	Resigned	2025-12-31	2025-12-23
Andrew Orth	Chief Commercial Officer	Resigned	2023-08-02	2023-08-07
Catherine Mazzacco	independent member of the Board	Appointed	2023-03-06	2023-03-06

Key facts CIK 1711279 CUSIP 501147102 13F (30d) 393 filings 392 filers Visit website Investor relations